We demonstrate a rapid reduction-bridging-double click sequence to yield dual-modality antibody conjugates using aryl selenols as novel disulfide reducing reagents and trifunctional dibromomaleimides (DBMs) as bridging reagents. This work will pr...

Artikel
A Fluorescence‐Based Assay for N5‐Carboxyaminoimidazole Ribonucleotide Mutase
Von Wiley-VCH zur Verfügung gestellt
A robust, fluorescence-based assay has been developed that relies on the reaction between the novel istain-fluorecein conjugate and the enzymatically generated compound, AIR. These compounds react non-enzymatically resulting in a highly fluorescent product. This unique reaction provides a new assay for monitoring the activity of the enzyme N5-CAIR mutase.
Abstract
The enzyme N5-carboxylaminoinidazole ribonucleotide (N5-CAIR) mutase is found in microbial de novo purine biosynthesis but is absent in humans making it an attractive antimicrobial target. N5-CAIR mutase catalyzes the synthesis of carboxyaminoimidazole ribonucleotide (CAIR) from N5-CAIR which is itself prepared from aminoimidazole ribonucleotide (AIR) by the enzyme N5-CAIR synthetase. During our research on identifying inhibitors of N5-CAIR mutase, we developed an innovative, fluorescence-based assay to measure the activity of this enzyme. This assay relies upon our recent serendipitous observation that AIR reversibly reacts with the compound isatin. Reaction of a fluorescently-tagged isatin with AIR resulted in a large increase in fluorescence intensity allowing a measurement of the concentration of AIR in solution. From this observation, we developed a reproducible, non-continuous assay that can replicate the known kinetic parameters of the enzyme and can readily detect a recognized inhibitor of the enzyme. This assay should find utility in screening for inhibitors targeting N5-CAIR mutase.
Zum VolltextÜberprüfung Ihres Anmeldestatus ...
Wenn Sie ein registrierter Benutzer sind, zeigen wir in Kürze den vollständigen Artikel.